SEPARATION AGREEMENT AND RELEASESeparation Agreement • December 18th, 2018 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
This Separation Agreement and Release (“Agreement”) is made by and between Stephen J. McAndrew, Ph.D. (“Employee”) and Oncobiologics, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
STRATEGIC PARTNERSHIP AGREEMENTStrategic Partnership Agreement • December 18th, 2018 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Strategic Partnership Agreement (the “Agreement”) by and between Oncobiologics, Inc., a Delaware corporation with a principal place of business at 7 Clarke Drive, Cranbury, New Jersey 08512 USA (“Oncobiologics”), and MTTR, LLC, a Delaware limited liability company, with a principal place of business at [***] (“MTTR”), is effective as of February 15, 2018 (the “Effective Date”). Oncobiologics and MTTR are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
LEASE TERMINATION AGREEMENTLease Termination Agreement • December 18th, 2018 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
THIS LEASE TERMINATION AGREEMENT is made as of the 28th day of August, 2018, by and between CEDAR BROOK EAST CORPORATE CENTER, LP, a New Jersey limited partnership, whose address is 4A Cedar Brook Drive, Cranbury, New Jersey 08512 (hereinafter referred to as "Landlord"); and ONCOBIOLOGICS, INC., a Delaware corporation, whose address is 7 Clarke Drive, Cranbury, New Jersey 08512 (hereinafter referred to as "Tenant").
